Presentation is loading. Please wait.

Presentation is loading. Please wait.

From: The Charles Bonnet Syndrome in Patients With Neovascular Age-Related Macular Degeneration: Association With Proton Pump Inhibitors Invest. Ophthalmol.

Published bySusanna Anthony Modified over 6 years ago

Similar presentations

Presentation on theme: "From: The Charles Bonnet Syndrome in Patients With Neovascular Age-Related Macular Degeneration: Association With Proton Pump Inhibitors Invest. Ophthalmol."— Presentation transcript:

1 From: The Charles Bonnet Syndrome in Patients With Neovascular Age-Related Macular Degeneration: Association With Proton Pump Inhibitors Invest. Ophthalmol. Vis. Sci ;58(10): doi: /iovs Figure Legend: ROC curve for the logistic regression model including, as predictors, the variables age, sex, PPI intake, and better eye BCVA. The variables follow-up and bilaterality did not influence the model and were excluded. AUC = Date of download: 10/26/2017 The Association for Research in Vision and Ophthalmology Copyright © All rights reserved.

Download ppt "From: The Charles Bonnet Syndrome in Patients With Neovascular Age-Related Macular Degeneration: Association With Proton Pump Inhibitors Invest. Ophthalmol."

Similar presentations

Invest. Ophthalmol. Vis. Sci ;48(10): doi: /iovs Figure Legend:

Invest. Ophthalmol. Vis. Sci ;48(10): doi: /iovs Figure Legend:
From: Enhanced Motion Aftereffects in Migraine Are Related to Contrast Sensitivity: Implications for Models of Differences in Precortical/Cortical Function.

From: Enhanced Motion Aftereffects in Migraine Are Related to Contrast Sensitivity: Implications for Models of Differences in Precortical/Cortical Function.
From: Increased Choroidal Neovascularization following Laser Induction in Mice Lacking Lysyl Oxidase-like 1 Invest. Ophthalmol. Vis. Sci.. 2008;49(6):2599-2605.

From: Increased Choroidal Neovascularization following Laser Induction in Mice Lacking Lysyl Oxidase-like 1 Invest. Ophthalmol. Vis. Sci ;49(6):
Invest. Ophthalmol. Vis. Sci ;57(1): doi: /iovs Figure Legend:

Invest. Ophthalmol. Vis. Sci ;57(1): doi: /iovs Figure Legend:
From: Predicting Future Self-Reported Motor Vehicle Collisions in Subjects with Primary Open-Angle Glaucoma Using the Penalized Support Vector Machine.

From: Predicting Future Self-Reported Motor Vehicle Collisions in Subjects with Primary Open-Angle Glaucoma Using the Penalized Support Vector Machine.
From: Postnatal Gene Expression in the Normal Mouse Cornea by SAGE

From: Postnatal Gene Expression in the Normal Mouse Cornea by SAGE
From: Glycogene Expression in Conjunctiva of Patients with Dry Eye: Downregulation of Notch Signaling Invest. Ophthalmol. Vis. Sci.. 2009;50(6):2666-2672.

From: Glycogene Expression in Conjunctiva of Patients with Dry Eye: Downregulation of Notch Signaling Invest. Ophthalmol. Vis. Sci ;50(6):
Invest. Ophthalmol. Vis. Sci ;49(1): doi: /iovs Figure Legend:

Invest. Ophthalmol. Vis. Sci ;49(1): doi: /iovs Figure Legend:
Invest. Ophthalmol. Vis. Sci ;52(1): doi: /iovs Figure Legend:

Invest. Ophthalmol. Vis. Sci ;52(1): doi: /iovs Figure Legend:
From: The Controlled-Environment Chamber: A New Mouse Model of Dry Eye

From: The Controlled-Environment Chamber: A New Mouse Model of Dry Eye
From: Blunt Eye Trauma: Empirical Histopathologic Paintball Impact Thresholds in Fresh Mounted Porcine Eyes Invest. Ophthalmol. Vis. Sci.. 2011;52(8):5157-5166.

From: Blunt Eye Trauma: Empirical Histopathologic Paintball Impact Thresholds in Fresh Mounted Porcine Eyes Invest. Ophthalmol. Vis. Sci ;52(8):
From: Topical Pazopanib Blocks VEGF-Induced Vascular Leakage and Neovascularization in the Mouse Retina but Is Ineffective in the Rabbit Invest. Ophthalmol.

From: Topical Pazopanib Blocks VEGF-Induced Vascular Leakage and Neovascularization in the Mouse Retina but Is Ineffective in the Rabbit Invest. Ophthalmol.
Invest. Ophthalmol. Vis. Sci ;54(3): doi: /iovs Figure Legend:

Invest. Ophthalmol. Vis. Sci ;54(3): doi: /iovs Figure Legend:
From: Meibomian Gland Dysfunction Model in Hairless Mice Fed a Special Diet With Limited Lipid Content Invest. Ophthalmol. Vis. Sci.. 2016;57(7):3268-3275.

From: Meibomian Gland Dysfunction Model in Hairless Mice Fed a Special Diet With Limited Lipid Content Invest. Ophthalmol. Vis. Sci ;57(7):
From: Targeted Administration into the Suprachoroidal Space Using a Microneedle for Drug Delivery to the Posterior Segment of the Eye Invest. Ophthalmol.

From: Targeted Administration into the Suprachoroidal Space Using a Microneedle for Drug Delivery to the Posterior Segment of the Eye Invest. Ophthalmol.
From: Stereotactic Radiosurgery for AMD: A Monte Carlo–Based Assessment of Patient-Specific Tissue Doses Invest. Ophthalmol. Vis. Sci.. 2011;52(5):2334-2342.

From: Stereotactic Radiosurgery for AMD: A Monte Carlo–Based Assessment of Patient-Specific Tissue Doses Invest. Ophthalmol. Vis. Sci ;52(5):
From: The Structural Role of Elastic Fibers in the Cornea Investigated Using a Mouse Model for Marfan Syndrome Invest. Ophthalmol. Vis. Sci.. 2017;58(4):2106-2116.

From: The Structural Role of Elastic Fibers in the Cornea Investigated Using a Mouse Model for Marfan Syndrome Invest. Ophthalmol. Vis. Sci ;58(4):
From: Which Members of a Community Need Antibiotics to Control Trachoma? Conjunctival Chlamydia trachomatis Infection Load in Gambian Villages Invest.

From: Which Members of a Community Need Antibiotics to Control Trachoma? Conjunctival Chlamydia trachomatis Infection Load in Gambian Villages Invest.
From: What You See Is What You Step: The Horizontal–Vertical Illusion Increases Toe Clearance in Older Adults During Stair Ascent Invest. Ophthalmol. Vis.

From: What You See Is What You Step: The Horizontal–Vertical Illusion Increases Toe Clearance in Older Adults During Stair Ascent Invest. Ophthalmol. Vis.
From: Development of a Rat Schematic Eye From In Vivo Biometry and the Correction of Lateral Magnification in SD-OCT Imaging Invest. Ophthalmol. Vis. Sci..

From: Development of a Rat Schematic Eye From In Vivo Biometry and the Correction of Lateral Magnification in SD-OCT Imaging Invest. Ophthalmol. Vis. Sci..

Similar presentations

Ads by Google